Amesika N. Nyaku

Statistics

Publications

Citations

357

H-Index

Active since

2017

Affiliations

Rutgers, The State University of New Jersey(Current)

Brigham and Women's Hospital

Harvard University

Northwestern University

University of Alabama at Birmingham

Amesika N. Nyaku is an author at Rutgers, The State University of New Jersey specializing in infectious diseases, pharmacotherapy, and antiviral therapy.

ORCID

Publications per year

2017–2023

Publications

ACTG A5353: A Pilot Study of Dolutegravir Plus Lamivudine for Initial Treatment of Human Immunodeficiency Virus-1 (HIV-1)–infected Participants With HIV-1 RNA <500000 Copies/mL

Babafemi Taiwo, Lu Zheng, Andrei Ștefănescu et al. · Clinical Infectious Diseases · 2017 · 96 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Dolutegravir Plus Lamivudine Maintains Human Immunodeficiency Virus-1 Suppression Through Week 48 in a Pilot Randomized Trial

Babafemi Taiwo, Vincent C. Marconi, Baiba Berzins et al. · Clinical Infectious Diseases · 2017 · 85 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +17

Perspectives of opioid use disorder treatment providers during COVID-19: Adapting to flexibilities and sustaining reforms

Peter Treitler, Cadence F. Bowden, James F. Lloyd et al. · Journal of Substance Abuse Treatment · 2021 · 65 citations · Full text

Nursing, Psychiatry, Pain Management +11

Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS)

Elizabeth Needham Waddell, Sandra A. Springer, Lisa A. Marsch et al. · Journal of Substance Abuse Treatment · 2021 · 23 citations · Full text

Nursing, Pharmacology, Pharmacotherapy +13

Clinical and Demographic Factors Associated With COVID-19, Severe COVID-19, and SARS-CoV-2 Infection in Adults

Deborah Theodore, Angela R Branche, Lily Zhang et al. · JAMA Network Open · 2023 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

1–5 of 9